Pathway | Size | NES | P value | FDR |
---|---|---|---|---|
Type I diabetes mellitus | 40 | − 0.78 | < 0.001 | < 0.001 |
Allograft rejection | 34 | − 0.76 | < 0.001 | < 0.001 |
Ribosome | 135 | − 0.74 | < 0.001 | < 0.001 |
Graft-versus-host disease | 36 | − 0.74 | < 0.001 | < 0.001 |
Intestinal immune network for IGA production | 44 | − 0.72 | < 0.001 | < 0.001 |
Autoimmune thyroid disease | 41 | − 0.70 | < 0.001 | 1.14e-5 |
Staphylococcus aureus infection | 87 | − 0.69 | < 0.001 | 9.77e-5 |
Asthma | 28 | − 0.69 | < 0.001 | 8.55e-5 |
Leishmaniasis | 74 | − 0.66 | < 0.001 | 4.64e-4 |
Primary bile acid biosynthesis | 17 | − 0.65 | 2.63e-3 | 6.96e-5 |
Systemic lupus erythematosus | 127 | − 0.64 | < 0.001 | 1.00e-3 |
Inflammatory bowel disease | 60 | − 0.63 | < 0.001 | 1.09e-3 |
Rheumatoid arthritis | 87 | − 0.63 | < 0.001 | 1.01e-3 |
Thiamine metabolism | 15 | − 0.6 | 2.67e-3 | 1.38e-3 |
Coronavirus disease | 220 | − 0.62 | < 0.001 | 1.84e-3 |
Viral myocarditis | 57 | − 0.61 | < 0.001 | 1.81e-3 |
Complement and coagulation cascades | 83 | − 0.60 | < 0.001 | 2.15e-3 |
Antigen processing and presentation | 69 | − 0.60 | < 0.001 | 2.11e-3 |
Pertussis | 76 | − 0.59 | < 0.001 | 2.99e-3 |
One carbon pool by folate | 20 | − 0.58 | 2.55e-3 | 3.65e-3 |